NEUROPHARMAGEN Trademark

Trademark Overview


On Monday, July 29, 2024, a trademark application was filed for NEUROPHARMAGEN with the United States Patent and Trademark Office. The USPTO has given the NEUROPHARMAGEN trademark a serial number of 98671767. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, June 16, 2025. This trademark is owned by PRECISION MOLECULAR SOLUTIONS LLC. The NEUROPHARMAGEN trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services; Medical diagnostic services; Medical analysis services for the treatment of persons; Genetic testing for medical purposes; Performing diagnosis of diseases; Medical analysis for the diagnosis and treatment of persons; Remote monitoring of medical data for medical diagnosis and treatment; Genetic analysis in order to increase the efficiency of treatments for patients for medical purposes; Services for the preparation of medical reports, namely, providing information to medical professionals in the form of reports in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services

Software as a service (SAAS) featuring software for information, advice and consultancy in the field of pharmacogenetics; Platform as a Service (PAAS) featuring computer platforms for information, advice and consultancy in the field of pharmacogenetics; Science and technology services, namely analysis in the field of pharmacogenetics; Genetic research; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Medical and pharmacological research services; Design and development of medical technology; Design and development of computer software for use with medical technology; Pharmaceutical products development; Research laboratory analysis in the field of genetics; Scientific research in the nature of conducting clinical trials for others; Structural and functional analysis of genomes; Research in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services
neuropharmagen

General Information


Serial Number98671767
Word MarkNEUROPHARMAGEN
Filing DateMonday, July 29, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, June 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "NEUROPHARMAGEN" in green lettering.
Indication of Colors claimedThe color green is claimed as a feature of the mark.
Goods and ServicesMedical services; Medical diagnostic services; Medical analysis services for the treatment of persons; Genetic testing for medical purposes; Performing diagnosis of diseases; Medical analysis for the diagnosis and treatment of persons; Remote monitoring of medical data for medical diagnosis and treatment; Genetic analysis in order to increase the efficiency of treatments for patients for medical purposes; Services for the preparation of medical reports, namely, providing information to medical professionals in the form of reports in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services
Goods and ServicesSoftware as a service (SAAS) featuring software for information, advice and consultancy in the field of pharmacogenetics; Platform as a Service (PAAS) featuring computer platforms for information, advice and consultancy in the field of pharmacogenetics; Science and technology services, namely analysis in the field of pharmacogenetics; Genetic research; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Medical and pharmacological research services; Design and development of medical technology; Design and development of computer software for use with medical technology; Pharmaceutical products development; Research laboratory analysis in the field of genetics; Scientific research in the nature of conducting clinical trials for others; Structural and functional analysis of genomes; Research in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 29, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 29, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePRECISION MOLECULAR SOLUTIONS LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBarcelona 08907
ES

Trademark Events


Event DateEvent Description
Monday, July 29, 2024NEW APPLICATION ENTERED
Wednesday, November 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 27, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 27, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 14, 2025ASSIGNED TO EXAMINER
Wednesday, February 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 19, 2025NON-FINAL ACTION E-MAILED
Wednesday, February 19, 2025NON-FINAL ACTION WRITTEN
Wednesday, November 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 13, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 16, 2025LETTER OF SUSPENSION E-MAILED
Monday, June 16, 2025SUSPENSION LETTER WRITTEN
Monday, June 16, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED